<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Therapy</journal-id><journal-title-group><journal-title xml:lang="en">Therapy</journal-title><trans-title-group xml:lang="ru"><trans-title>Терапия</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2412-4036</issn><issn publication-format="electronic">2713-1823</issn><publisher><publisher-name xml:lang="en">Bionika Media</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">288819</article-id><article-id pub-id-type="doi">10.18565/therapy.2022.2.96-102</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">DIFFERENTIAL DIAGNOSIS OF SJOGREN'S DISEASE</article-title><trans-title-group xml:lang="ru"><trans-title>ДИФФЕРЕНЦИАЛЬНАЯ ДИАГНОСТИКА БОЛЕЗНИ ШЕГРЕНА</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>TORGASHINA</surname><given-names>Anna V.</given-names></name><name xml:lang="ru"><surname>ТОРГАШИНА</surname><given-names>Анна Васильевна</given-names></name></name-alternatives><bio xml:lang="en"><p>PhD, head of the Laboratory of rare rheumatic diseases and Sjogren's disease</p></bio><bio xml:lang="ru"><p>к.м.н., зав. лабораторией редких ревматических заболеваний и болезни Шегрена</p></bio><email>anna.torgashina@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">V.A. Nasonova Research Institute of Rheumatology</institution></aff><aff><institution xml:lang="ru">ФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой»</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2022-02-15" publication-format="electronic"><day>15</day><month>02</month><year>2022</year></pub-date><volume>8</volume><issue>2</issue><issue-title xml:lang="en">VOL 8, NO2 (2022)</issue-title><issue-title xml:lang="ru">ТОМ 8, №2 (2022)</issue-title><fpage>96</fpage><lpage>102</lpage><history><date date-type="received" iso-8601-date="2023-02-26"><day>26</day><month>02</month><year>2023</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2022, Bionika Media</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2022, ООО «Бионика Медиа»</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="en">Bionika Media</copyright-holder><copyright-holder xml:lang="ru">ООО «Бионика Медиа»</copyright-holder></permissions><self-uri xlink:href="https://journals.eco-vector.com/2412-4036/article/view/288819">https://journals.eco-vector.com/2412-4036/article/view/288819</self-uri><abstract xml:lang="en"><p>The article describes differential diagnosis of Sjogren's syndrome, in particular, various causes of the most common clinical manifestations such as sicca syndrome and sialomegaly are discussed. The possible causes of both underdiagnosis and overdiagnosis of Sjogren's syndrome are analyzed.</p></abstract><trans-abstract xml:lang="ru"><p>В статье рассматриваются вопросы дифференциальной диагностики болезни Шегрена, в частности, обсуждаются различные причины таких наиболее распространенных клинических проявлений, как сухой синдром и сиаломегалия. Проанализированы возможные причины как гиподиагностики, так и гипердиагностики болезни Шегрена.</p></trans-abstract><kwd-group xml:lang="en"><kwd>Sjogren's disease</kwd><kwd>sicca syndrome</kwd><kwd>sialomegaly</kwd><kwd>MALT lymphoma</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>болезнь Шегрена</kwd><kwd>сухой синдром</kwd><kwd>сиаломегалия</kwd><kwd>MALT-лимфома</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Сафонова Т.Н., В.И. Васильев, Лихванцева В.Г. Синдром Шегрена: руководство для врачей. Под ред. В.Г Лихванцевой. М.: 101 Издательство Московского университета. 2013; 600 с. [Safonova T.N., V.I. Vasiliev, Likhvantseva V.G. Sjogren's syndrome: a guide for physicians. Ed. by Likhvantseva V.G. Moscow; Moscow University Press. 2013; 600 pp. (In Russ.)]. ISBN: 978-5-19-010836-1.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Qin, B., Wang, J., Yang, Z. et al. Epidemiology of primary Sjogren's syndrome: A systematic review and meta-analysis. Ann Rheum Dis. 2014; 74(11): 1983-89. https://dx.doi.org/10.1136/annrheumdis-2014-205375.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Shiboski C.H., Shiboski S.C., Seror R. et al. 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjogren's syndrome: A consensus and data-driven methodology involving three international patient cohorts. Arthritis Rheumatol. 2017; 69(1): 35-45. https://dx.doi.org/10.1002/art.39859.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Helmick C.G., Felson D.T., Lawrence R.C. et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum. 2008; 58(1): 15-25. https://dx.doi.org/10.1002/art.23177.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Hopcraft M.S., Tan C. Xerostomia: An update for clinicians. Aust Dent J. 2010; 55(3): 238-44; quiz 353. https://dx.doi.org/10.1111/j.1834-7819.2010.01229.x.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Cartee D.L., Maker S., Dalonges D., Manski M.C. Sjogren's syndrome: Oral manifestations and treatment, a dental perspective. J Dent Hyg. 2015; 89(6): 365-71.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Kaplan I., Zuk-Paz L., Wolff A. Association between salivary flow rates, oral symptoms, and oral mucosal status. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008; 106(2): 235-41. https://dx.doi.org/10.1016/j.tripleo.2007.11.029.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Российские клинические рекомендации. Ревматология. Под ред. Е.Л. Насонова. М.: ГЭОТАР-Медиа. 2017; 464 с. ISBN: 978-5-9704-4261-6.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Wick J.Y. Xerostomia: Causes and treatment. Consult Pharm. 2007; 22(12): 985-92. https://dx.doi.org/10.4140/tcp.n.2007.985.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Beckman K.A., Luchs J., Milner M.S. Making the diagnosis of Sjogren's syndrome in patients with dry eye. Clin Ophthalmol. 2015; 10: 43-53. https://dx.doi.org/10.2147/OPTH.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Akpek E.K., Bunya V.Y., Saldanha I.J. Sjogren's syndrome: More than just dry eye. Cornea. 2019; 38(5): 658-61. https://dx.doi.org/10.1097/ICO.0000000000001865.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Murtagh P., Comer R., Fahy G. Corneal perforation in undiagnosed Sjogren's syndrome following topical NSAID and steroid drops post routine cataract extraction. BMJ Case Rep. 2018; 2018: bcr2018225428. https://dx.doi.org/10.1136/bcr-2018-225428.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Liu K.C., Huynh K., Grubbs J. Jr., Davis R.M. Autoimmunity in the pathogenesis and treatment of keratoconjunctivitis sicca. Curr Allergy Asthma Rep. 2014; 14(1): 403. https://dx.doi.org/10.1007/s11882-013-0403-7.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Zeev M.S., Miller D.D., Latkany R. Diagnosis of dry eye disease and emerging technologies. Clin Ophthalmol. 2014; 8: 581-90. https://dx.doi.org/10.2147/OPTH.S45444.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Liao R., Yang H.T., Li H. Recent advances of salivary gland biopsy in Sjogren's syndrome. Front Med (Lausanne). 2022; 8: 792593. https://dx.doi.org/10.3389/fmed.2021.792593.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Васильев В.И., Гайдук И.В., Пальшина С.Г с соавт. Первичные онкогематологические заболевания, дебютирующие с поражения больших слюнных желез в ревматологической практике. Современная ревматология. 2019; 1: 44-51. https://dx.doi.org/10.14412/1996-7012-2019-1-44-51.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Cheah C.Y. Marginal zone lymphoma: present status and future perspectives. Haematologica. 2022; 107(1): 35-43. https://dx.doi.org/10.3324/haematol.2021.278755.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Akiyama M., Takanashi S., Takeuchi T. Salivary gland involvement in ANCA-associated vasculitis. Autoimmun Rev. 2021; 20(11): 102940. https://dx.doi.org/10.1016/j.autrev.2021.102940.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Сокол Е.В. IgG4-связанное заболевание: что мы знаем 20 лет спустя. Терапевтический архив. 2020; 5: 104-109. https://dx.doi.org/10.26442/00403660.2020.05.000632.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Puxeddu I., Capecchi R., Carta F. et al. Salivary gland pathology in IgG4-related disease: A comprehensive review. J Immunol Res. 2018; 2018: 6936727. https://dx.doi.org/10.1155/2018/6936727.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Сокол Е.В. Новые классификационные критерии IgG4-связанного заболевания Американской коллегии ревматологов (ACR)/ Европейской антиревматической лиги (EULAR), 2019. Научно-практическая ревматология. 2020; 4: 368-375. https://dx.doi.org/10.47360/1995-4484-2020-368-375.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Chen S., Paul B.C., Myssiorek D. An algorithm approach to diagnosing bilateral parotid enlargement. Otolaryngol Head Neck Surg 2013; 148(5): 732-39. https://dx.doi.org/10.1177/0194599813476669.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Scully C., Bagan J.V., Eveson J.W. et al. Sialosis: 35 cases of persistent parotid swelling from two countries. Br J Oral Maxillofac Surg. 2008; 46(6): 468-72. https://dx.doi.org/10.1016/j.bjoms.2008.01.014.</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Ogle O.E. Salivary gland diseases. Dent Clin North Am. 2020; 64(1): 87-104. https://dx.doi.org/10.1016/j.cden.2019.08.007.</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Li Х., Zhao Y-N., Zhang L-Q. Differences between radioactive iodine-induced sialadenitis and chronic obstructive parotitis.Int J Oral Maxillofac Surg. 2021; S0901-5027(21)00391-X. https://dx.doi.org/10.1016/j.ijom.2021.11.003.</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Meer S. Human immunodeficiency virus and salivary gland pathology: an update. Oral Surg Oral Med Oral Pathol Oral Radiol. 2019; 128(1): 52-59. https://dx.doi.org/10.1016Zj.oooo.2019.01.001.</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Ghrenassia E., Martis N., Boyer J. et al. The diffuse infiltrative lymphocytosis syndrome (DILS). J Autoimmun. 2015; 59: 19-25. https://dx.doi.org/10.1016/j-jaut.2015.01.010.</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Kim Y.H., Jeong W.J., Jung K.Y. et al. Diagnosis of major salivary gland tuberculosis: experience of eight cases and review of the literature. Acta Otolaryngol. 2005; 125(12): 1318-22. https://dx.doi.org/10.1080/00016480510012246.</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Seve P., Pacheco Y., Durupt F. et al. Sarcoidosis: A clinical overview from symptoms to diagnosis. Cells. 2021; 10(4): 766. https://dx.doi.org/10.3390/cells10040766.</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Saarilahti K., Kouri M., Collan J. et al.Intensity modulated radio-therapy for head and neck cancer: Evidence for preserved salivary gland function. Radiother Oncol. 2005; 74(3): 251-58. https://dx.doi.org/10.1016/j.radonc.2004.11.004.</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Young A., Okuyemi O.T. Benign salivary gland tumors. 2021. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan. PMID: 33231965.</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Moreddu E., Baumstarck-Barrau K., Gabriel S. et al. Incidence of salivary side effects after radioiodine treatment using a new specifically-designed questionnaire. Br J Oral Maxillofac Surg. 2017; 55(6): 609-12. https://dx.doi.org/10.1016/j.bjoms.2017.03.019.</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Agaimy A. Papillary neoplasms of the salivary duct system: A review. Surg Pathol Clin. 2021; 14(1): 53-65. https://dx.doi.org/10.1016/j.path.2020.09.007.</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Alnoor F., Gandhi J.S., Stein M.K. et al. Follicular lymphoma diagnosed in warthin tumor: a case report and review of the literature. Head Neck Pathol. 2020; 14(2): 386-91. https://dx.doi.org/10.1007/s12105-019-01045-x.</mixed-citation></ref></ref-list></back></article>
